Skip to main content
    A

    ARS Pharmaceuticals, Inc (SPRY)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.59
    -0.30 (-7.71%)

    Market Cap: $391.06M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    ARS Pharmaceuticals, Inc (SPRY) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to ARS Pharmaceuticals are Arcturus Therapeutics Holdings (ARCT), Rocket Pharmaceuticals (RCKT) and Rezolute (RZLT). By market cap, ARS Pharmaceuticals ranks 7th of the 13 companies on this page; Ardelyx (ARDX) is the largest at $776.74M.

    Peer Comparison

    SPRY's revenue growth of 16.0% is above the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    ARS Pharmaceuticals (SPRY)$391.06MN/A2.9x-163.6%-143.8%16.0%0.00%
    Arcturus Therapeutics Holdings Inc (ARCT)$240.96MN/A7.7x-285.9%N/A6.7%0.00%
    Rocket Pharmaceuticals Inc (RCKT)$256.82MN/AN/A0.0%-2.3%0.0%0.00%
    Rezolute Inc (RZLT)$353.54MN/AN/A0.0%N/A0.0%0.00%
    Ardelyx Inc (ARDX)$776.74MN/A1.6x-11.8%-6.5%15.7%0.00%
    Fennec Pharmaceuticals Inc (FENC)$410.25M159.5x6.8x3.0%N/A57.3%0.00%
    Enanta Pharmaceuticals Inc (ENTA)$320.09MN/A4.8x-96.9%N/A-21.6%0.00%
    Alector Inc (ALEC)$378.15M7.3x1.7x23.9%N/A4896.0%0.00%
    Prothena Corporation plc (PRTA)$419.01MN/A7.8x-45.4%N/A-74.3%0.00%
    Surrozen Inc (SRZN)$602.54MN/A36.1x0.0%N/A408.6%0.00%
    SAB Biotherapeutics Inc (SABS)$266.66MN/AN/A0.0%N/A-62.4%0.00%
    Avalo Therapeutics Inc (AVTX)$448.71MN/AN/A0.0%N/A-69.3%0.00%
    Indaptus Therapeutics Inc (INDP)$422.38MN/AN/A0.0%N/A0.0%0.00%
    Peer median$394.20M83.4x6.8x0.0%-4.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to ARS Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Arcturus Therapeutics Holdings Inc (ARCT)
    Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases.
    ARCT competitors
    Rocket Pharmaceuticals Inc (RCKT)
    Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases.
    RCKT competitors
    Rezolute Inc (RZLT)
    Rezolute, Inc., a clinical-stage biopharmaceutical company, develops rare and metabolic disease therapies in the United States.
    RZLT competitors
    Ardelyx Inc (ARDX)
    Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States...
    ARDX competitors
    Fennec Pharmaceuticals Inc (FENC)
    Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops candidate products for use in the treatment of cancer in the United States.
    FENC competitors
    Enanta Pharmaceuticals Inc (ENTA)
    Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.
    ENTA competitors
    Alector Inc (ALEC)
    Alector, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of neurodegenerative diseases.
    ALEC competitors
    Prothena Corporation plc (PRTA)
    Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases...
    PRTA competitors
    Surrozen Inc (SRZN)
    Surrozen Inc. is a clinical-stage biopharmaceutical company at the forefront of developing innovative therapeutics using its proprietary SIRPa-IgG platform...
    SRZN competitors
    SAB Biotherapeutics Inc (SABS)
    SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology.
    SABS competitors
    Avalo Therapeutics Inc (AVTX)
    Avalo Therapeutics Inc is a forward-thinking clinical-stage biotechnology company focused on developing transformative therapies for rare and underserved...
    AVTX competitors
    Indaptus Therapeutics Inc (INDP)
    Indaptus Therapeutics Inc. is a pioneering biotechnology firm focused on advancing immunotherapies that aim to transform cancer treatment paradigms.
    INDP competitors

    Frequently Asked Questions About SPRY

    Who are ARS Pharmaceuticals' main competitors?

    The companies most similar to ARS Pharmaceuticals include Arcturus Therapeutics Holdings (ARCT), Rocket Pharmaceuticals (RCKT), Rezolute (RZLT), Ardelyx (ARDX) and Fennec Pharmaceuticals (FENC), listed from the closest match.

    Who is ARS Pharmaceuticals' biggest competitor?

    Ardelyx (ARDX) is the largest of the similar companies at $776.74M; Arcturus Therapeutics Holdings (ARCT) is the closest match by business profile, size, sector and industry.

    How does SPRY stock compare with its competitors?

    SPRY's P/S is 2.9x against a peer median of 6.8x; its net margin is -163.6% against a peer median of 0.0%.

    Which of ARS Pharmaceuticals' competitors pays a higher dividend?

    ARS Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is ARS Pharmaceuticals bigger than its competitors?

    No. ARS Pharmaceuticals is 7th by market cap among the 13 companies on this page; the largest is Ardelyx (ARDX) at $776.74M.